Lv31
364 积分 2024-06-13 加入
MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
6天前
已完结
Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease
6天前
已完结
Therapeutic targeting of the functionally elusive TAM receptor family
6天前
已完结
TAM family kinases as therapeutic targets at the interface of cancer and immunity
6天前
已完结
370-OR: Optimized Weight Loss with Bimagrumab—Reduced Fat Mass with Increased Muscle Mass by Appetite-Independent Mechanisms
7天前
已完结
Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with In Vivo Target Engagement
13天前
已完结
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor
13天前
已完结
Structure-Guided Design and Synthesis of Pyridinone-Based Selective Bromodomain and Extra-Terminal Domain (BET)-First Bromodomain (BD1) Inhibitors
18天前
已完结
Synthesis, Optimization, and Structure–Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs)
18天前
已完结
Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity
19天前
已完结
皖公网安备34019202002308
